# Immunitas Therapeutics, Inc. — Form D

Immunitas Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-24. The offering totals $57.7M, of which $29.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-08-24
- Form: D
- Accession: 0001879910-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $57.7M
- Amount sold: $29.1M
- Remaining: $28.6M
- Investors: 21
- Date of first sale: 2021-08-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-411076

## Issuer

- Name: Immunitas Therapeutics, Inc.
- CIK: 0001879910
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 830 WINTER STREET, 2ND FLOOR, WALTHAM, MA, 02451
- Phone: 781-810-9292

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Laura Brass | Director | BOSTON, MA |
| Juergen Eckhardt | Director | Emeryville, CA |
| JEFFREY GOLDBERG | Director | Bellville, TX |
| Jiaping Gu | Director | Seattle, WA |
| Lucio Iannone | Director | Watertown, MA |
| Christoph Westphal | Director | CAMBRIDGE, MA |
| Kai Wucherpfennig | Director | Waltham, MA |
| JEFFREY GOLDBERG | Executive Officer | Bellville, TX |
| Dan Matloff | Executive Officer | Waltham, MA |
| Amanda Wagner | Executive Officer | Waltham, MA |

## More

- [CIK 1879910 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1879910&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001879910-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.